Canine models of asthma and COPD

Area of Science:

• Comparative Medicine
• Respiratory Physiology
• Pharmacology

Background:

• Asthma and Chronic Obstructive Pulmonary Disease (COPD) are significant human respiratory conditions.
• Developing accurate animal models is crucial for understanding disease pathogenesis and evaluating therapeutic interventions.

Purpose of the Study:

• To review the utility of canine models in studying asthma and COPD.
• To highlight how these models advance our comprehension of respiratory disease pathology, pathophysiology, and treatment.

Main Methods:

• Dogs exhibit asthma-like symptoms (airflow obstruction, inflammation, hyperresponsiveness) after antigen challenge, hyperventilation, or ozone inhalation.
• COPD models are induced via cigarette smoke, sulfur dioxide, or proteolytic enzymes (e.g., papain).
• Efficacy of standard asthma medications (beta-agonists, corticosteroids, leukotriene inhibitors) is demonstrated in canine asthma models.

Main Results:

• Canine models successfully mimic key pathological and physiological aspects of human asthma and COPD.
• These models have been instrumental in preclinical evaluation of novel treatments and methodologies for respiratory diseases.
• Standard anti-asthma drugs prove effective in canine models, validating their therapeutic potential.

Conclusions:

• Canine models provide valuable insights into the pathology and pathophysiology of human asthma and COPD.
• Their use facilitates the development and testing of effective therapeutic strategies for these prevalent respiratory disorders.
• Continued utilization of these models is essential for advancing respiratory medicine.